Chronic News and Research

RSS

Combating a frequently overlooked assassin: Water

When a hurricane, earthquake or wildfire strikes, a variety of supplies and equipment is needed to respond and aid victims. But, clean water is a common denominator; its demand is chronic and ubiquitous. In fact, dirty water is one of Mother Nature's overlooked assassins. More than one million people perish each year after imbibing it, and according to the World Health Organization, more than one billion people lack access to its clean counterpart.

12 Apr 2010

Kidney disease genes discovered

Chronic kidney disease affects one in 10 adults and can severely damage a patient’s quality of life over years. This disease is linked to advanced age with one in five men and one in four women aged between 65 and 74 developing some degree of kidney damage.

12 Apr 2010

Johns Hopkins Hospital launches Meatless Monday campaign to encourage healthier

The Johns Hopkins Hospital will launch a campaign on Monday, April 12 to encourage healthier eating among patients, visitors and staff — Meatless Monday.

12 Apr 2010

S. thermophilus CRL 1190-fermented milk effective in therapeutic treatment of chronic gastritis: Research

Gastritis produced by acetyl-salicylic acid consumption is a common disorder worldwide. The use of probiotics has been proposed to ameliorate different gastrointestinal tract diseases such as inflammatory bowel disease, diarrhea, irritable bowel syndrome, etc. However, little attention has been paid to the use of probiotics in gastric disease.

12 Apr 2010

FDA issues complete response letter regarding the NDA for OMAPRO

ChemGenex Pharmaceuticals announces that the U.S. Food and Drug Administration's Office of Oncology Drug Products has issued a complete response letter regarding the new drug application for OMAPRO for the treatment of adults with chronic myeloid leukemia who have failed prior therapy with imatinib and have the Bcr-Abl T315I mutation.

12 Apr 2010

New TIVR telephone system to teach pain management skills to patients with arthritis

Joan Broderick, Ph.D., Research Associate Professor, Department of Psychiatry and Behavioral Sciences at Stony Brook University, has received a $606,000 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health.

12 Apr 2010

Scientists discover and block pathway responsible for link between stress, anxiety and depression

Scientists at The University of Western Ontario have discovered the biological link between stress, anxiety and depression. By identifying the connecting mechanism in the brain, this high impact research led by Stephen Ferguson of Robarts Research Institute shows exactly how stress and anxiety could lead to depression.

12 Apr 2010

Research roundup: The effects of health IT, doctor-owned treatment centers, long-term care issues

Physician-Ownership Of Ambulatory Surgery Centers Linked To Higher Volume Of Surgeries - The authors analyzed data from Florida, using the Healthcare Cost and Utilization Project's State Ambulatory Surgery Databases, revealing "a significant association between physician-ownership of surgicenters and greater use" of certain outpatient procedures.

9 Apr 2010

Medtronic named 2010 MDEA winner for excellence in medical device design

Medtronic announced today that the company was named a 2010 Medical Device Excellence Award winner for excellence in medical device design for its Hydrodebrider System, manufactured by the company's Ear Nose and Throat business unit.

9 Apr 2010

Gamma-tocotrienol kills prostate tumour cells in animal model studies

Researchers from Davos Life Science in Singapore, in collaboration with scientists at the University of Hong Kong, have shown that gamma-tocotrienol, a member of the vitamin E family, is potent in killing prostate tumour cells in animal model studies. This research was reported this week in the latest edition of Pharmacology.

9 Apr 2010

More public-private partnerships crucial for success of Italian pharmaceutical industry

The newly retired Chief Executive Officer of Roche Pharmaceuticals Bill Burns today led calls for more public-private partnerships in the pharmaceutical industry at the launch of the Italian Institute of Technology's Drug Discovery and Development Unit (D3).

9 Apr 2010

Gelatinase B expression enhanced in gastric cancer compared to normal gastric mucosa

Gastric cancer in Mexico is the most frequent gastrointestinal malignant neoplasm. Several precursor conditions, such as chronic gastritis, have been associated with the development of gastric cancer. The gelatinases MMP-2 and MMP-9, members of the metalloproteinase family, are fundamental enzymes in extracellular matrix remodelling. The extracellular matrix is composed of secreted molecules outside cells which provides structural support and regulates cell behaviour.

9 Apr 2010

Inovio Biomedical receives $2.8M grant to develop DNA vaccine for HCV

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company and its collaborators from Drexel University, Cheyney University, and the University of Pennsylvania have received a $2.8 million grant to develop a DNA vaccine to treat hepatitis C virus.

9 Apr 2010

Nurses for Medicare expresses disappointment against implementation of user fees for medical visits

Nurses for Medicare expressed its disappointment at the Quebec government's decision to implement user fees for medical visits. In addition to a new health tax that does not vary according to income, the recent Quebec budget calls for patients to pay a $25 fee for each visit.

9 Apr 2010

IFN therapy for chronic hepatitis C must be individualized and optimized for efficacy

The efficacy of interferon (IFN) therapy depends on the hepatitis C virus (HCV) genotype, pretreatment viral load and early viral kinetics. Thus, IFN therapy must be individualized and optimized according to the virological and clinical status of each patient.

9 Apr 2010

"Nanovaccine" reverses diabetes

A new study, published online April 8 by Cell Press in the journal Immunity, describes a unique therapeutic "nanovaccine" that successfully reverses diabetes in a mouse model of the disease. In addition to providing new insight into diabetes, the research also reveals an aspect of the pathogenesis of the autoimmune response that may provide a therapeutic strategy for multiple autoimmune disorders.

9 Apr 2010

Researchers make dramatic strides in understanding and treating leukemia

In the past decade, researchers have made dramatic strides in understanding and treating leukemia, according to the April issue of Mayo Clinic Health Letter.

9 Apr 2010

Nanotechnology-based vaccine cures mice with type 1 diabetes

Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes, and could even have implications for other autoimmune diseases.

9 Apr 2010

McKesson Asia Pacific to be sold to Medibank Private

McKesson Corporation, the world's leading healthcare services company, today announced that it has signed a definitive agreement to sell its McKesson Asia Pacific business to Medibank Private Ltd., the largest private health services and insurer in Australia. The acquisition is expected to close in the second calendar quarter of 2010, subject to customary conditions, including regulatory review in Australia.

9 Apr 2010

Combination telaprevir treatment beneficial for retreatment of hepatitis C

A study co-authored by a Saint Louis University researcher found telaprevir, a protease inhibitor, combined with standard hepatitis C treatment, cures a significantly higher number of difficult-to-treat patients than standard treatment alone. The findings were published in the April issue of the New England Journal of Medicine.

9 Apr 2010

Chronic News and Research

Combating a frequently overlooked assassin: Water

Kidney disease genes discovered

Johns Hopkins Hospital launches Meatless Monday campaign to encourage healthier

S. thermophilus CRL 1190-fermented milk effective in therapeutic treatment of chronic gastritis: Research

FDA issues complete response letter regarding the NDA for OMAPRO

New TIVR telephone system to teach pain management skills to patients with arthritis

Scientists discover and block pathway responsible for link between stress, anxiety and depression

Research roundup: The effects of health IT, doctor-owned treatment centers, long-term care issues

Medtronic named 2010 MDEA winner for excellence in medical device design

Gamma-tocotrienol kills prostate tumour cells in animal model studies

More public-private partnerships crucial for success of Italian pharmaceutical industry

Gelatinase B expression enhanced in gastric cancer compared to normal gastric mucosa

Inovio Biomedical receives $2.8M grant to develop DNA vaccine for HCV

Nurses for Medicare expresses disappointment against implementation of user fees for medical visits

IFN therapy for chronic hepatitis C must be individualized and optimized for efficacy

"Nanovaccine" reverses diabetes

Researchers make dramatic strides in understanding and treating leukemia

Nanotechnology-based vaccine cures mice with type 1 diabetes

McKesson Asia Pacific to be sold to Medibank Private

Combination telaprevir treatment beneficial for retreatment of hepatitis C

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News